MDbio launches clinical trials for pharmaceutical quality

Los Angeles, July 22 28, 2022 (GLOBE NEWSWIRE) — Today, MDbio, in collaboration with its research partners at Radicle Science, announces the start of three separate clinical trial studies that will evaluate the effectiveness of individual products that target insomnia, pain and stress. The objective of the clinical trials is to understand the effectiveness of three new MDbio herbal products. During trials, doctors will test synergistic results in multi-active formula compounds and determine the effects of drug holidays using herbal medicines. MDbio will test its current range of products; MDsleep™, MDrelief™ and MDcalm™ on over 2,500 US adults. Trials will last 4 weeks, with the first trial starting in August. All three products have already undergone extensive internal observational trials, partially tested on patients in their own practice suffering from the corresponding disease.

“We are excited to team up with Dr. Chen and his colleagues to obtain large-scale efficacy trial data on our current product portfolio. Their team embodies our commitment to developing products based on real scientific results and to working with our patients and customers to continually refine and improve our product offering. Today, we continue our investment in the development of safe and effective drugs. said Brenden Dougherty, CEO of MDbio.

The highly anticipated clinical trial results will likely be made available to the public in the first quarter of 2023. MDbio currently sells all three products for purchase on its website.

MDbio is a leading herbal medicine company selling safe pharmaceutical grade products. Founded by four award-winning physicians with distinguished and successful careers at America’s top hospitals and medical centers. MDbio develops products that restore balance (homeostasis) to the body during periods of insomnia, anxiety, pain and other common situations. Our doctors seek not only to restore well-being to patients, but a real “joie de vivre” by researching, testing and refining natural ingredients that promote good health. Learn more at www.mdbiowellness.com.

Root science is an AI-driven health technology B-corp providing the first-ever scalable path to validating and predicting the effects of health and wellness products, transforming them into democratized precision solutions for ailments or improvement of human function. Radicle Science leverages a proprietary data analytics platform and direct-to-consumer (D2C) virtual clinical trial model to provide objective data on health outcomes across diverse populations and conditions, all at a fraction of the cost and time of traditional methods. The Radicle Vision is a future where patients trust affordable and accessible health and wellness products that are recommended by healthcare providers, reimbursed by insurance, and used as widely as pharmaceutical drugs. Learn more at www.RadicleScience.com.

What consumers can expect from three new herbal medicines

The founders of MDbio have become renowned for their use of herbal compounds to create effective medicines. Over their combined 80 years of service in healthcare, the founders of MDbio have found it increasingly clear that prescription drugs for sleep disorders, anxiety and pain relief are a double-edged sword. . Although these drugs are effective, they can also be toxic, harmful, or addictive to patients.

After many years of using herbal compounds, MDbio has concluded that herbal medicines, including phytocannabinoids, provide patients with real benefits without appreciable side effects. These drugs had undeniable potential to help reduce suffering and improve patient outcomes.

These drugs will be backed by vigorous testing and trial data and will provide patients with herbal alternatives that can restore balance (homeostasis) to the body during times of insomnia, anxiety, pain and depression. other common situations.

Leverage learnings and experience and provide resources for a digital world:

While the results of the clinical trials of these three new herbal medicines are eagerly awaited, MDbio and its team of specialists are not resting on their laurels. They recently launched their Doctor’s Desk (Resource Center), which contains lots of free information and inspiration for better nourishment of the mind and body.

For more information, please contact MDbio directly at [email protected] or 800-447-1485.

Source: https://thenewsfront.com/mdbio-starts-clinical-trials-for-pharmaceutical-grade-products-that-target-sleeplessness-stress-and-pain/